Chembio Diagnostics, Inc. (NASDAQ:CEMI)

Friday, December 21, 2012 | Web News
Receives FDA Approval for DPP(R) Point-of-Care HIV 1/2 Rapid Test (source)
See All Research...

No description is available at this time.